Toronto - Free Realtime Quote CAD

Helix BioPharma Corp. (HBP.TO)

0.9600

+0.0100

+(1.05%)

As of 1:31:49 PM EDT. Market Open.

Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers

TORONTO, ONTARIO - April 24, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vi...

NewMediaWire 14 days ago

HBPCF
Helix BioPharma Corp. Announces Voting Results From Its Annual General and Special Meeting

TORONTO, ONTARIO - March 26, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vi...

NewMediaWire last month

HBPCF
Is Helix BioPharma (TSE:HBP) In A Good Position To Deliver On Growth Plans?

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Simply Wall St. last month

HBPCF
Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain

TORONTO, ONTARIO - March 11, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vi...

NewMediaWire last month

HBPCF
Helix Biopharma Corp. Expands Leadership Team With World-Class Oncology and Scientific Experts

TORONTO, ONTARIO - March 6, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vin...

NewMediaWire 2 months ago

HBPCF
Helix Biopharma: Fiscal Q4 Earnings Snapshot

TORONTO (AP) — Helix Biopharma Corp. HBPCF) on Thursday reported a loss of $3.9 million in its fiscal fourth quarter. The Toronto-based company said it had a loss of 8 cents per share.

Associated Press Finance 6 months ago

HBPCF

Performance Overview

Return	HBP.TO	S&P/TSX Composite index (^GSPTSE)
YTD	+10.34%	+2.82%
1-Year	-16.52%	+13.14%
3-Year	-16.52%	+26.58%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Helix BioPharma Corp. (HBP.TO)

Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers

Helix BioPharma Corp. Announces Voting Results From Its Annual General and Special Meeting

Is Helix BioPharma (TSE:HBP) In A Good Position To Deliver On Growth Plans?

Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain

Helix Biopharma Corp. Expands Leadership Team With World-Class Oncology and Scientific Experts

Helix Biopharma: Fiscal Q4 Earnings Snapshot

Performance Overview